334 Followers on Owler

Roivant

is a New York-based biotechnology company that researches and develops novel therapies for the treatment of neurological and endocrine diseases... Read more
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Roivant

is a New York-based biotechnology company that researches and develops novel therapies for the treatment of neurological and endocrine diseases... Read more
Roivant CEO: Matthew Gline

CEO

Matthew Gline

CEO Approval Rating

82/100

2014

PublicNASDAQROIV

Pharmaceuticals & Biotechnology
Biotechnology
28342836 NAICS listing

Annual Revenue
$8.3M
Employees
860
Funding
$2.1B
Acquisitions
2
Investments
9

News

investment
Jan 12, 2026
https://www.finsmes.com/2026/01/proxima-raises-80-in-seed-funding.html
Roivant Sciences Ltd. has invested $80M in Proxima

Roivant Competitors

1Espero Biopharma
2Denovo Biopharma
3Kallyope
4Galapagos
5Idorsia
6Cardior
7Arrowhead
8Alnylam
9Acerus
10NeRRe
Unlock 13 + competitors

Trending Companies